Bioxytran, Inc. (BIXT)
OTCMKTS · Delayed Price · Currency is USD
0.0900
-0.0040 (-4.27%)
Aug 1, 2025, 2:08 PM EDT
Bioxytran Employees
Bioxytran had 3 employees as of December 31, 2023. The number of employees increased by 1 or 50.00% compared to the previous year.
Employees
3
Change (1Y)
1
Growth (1Y)
50.00%
Revenue / Employee
n/a
Profits / Employee
n/a
Market Cap
8.01M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 3 | 1 | 50.00% |
| Dec 31, 2022 | 2 | 0 | - |
| Dec 31, 2021 | 2 | 0 | - |
| Dec 31, 2020 | 2 | 0 | - |
| Dec 31, 2019 | 2 | 0 | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Endo, Inc. | 3,116 |
| Tian'an Technology Group | 8 |
| Elite Pharmaceuticals | 68 |
| Glass House Brands | 374 |
| CytoDyn | 13 |
| Northwest Biotherapeutics | 25 |
| American Oncology Network | 1,914 |
| Silence Therapeutics | 116 |
Bioxytran News
- 6 weeks ago - Bioxytran Secures a Source of GMP Quality Camel Hemoglobin - GlobeNewsWire
- 2 months ago - Bioxytran's Groundbreaking Stroke & Alzheimer's Tech Gains Validation That Measures Oxygenation Uptake During Strokes - GlobeNewsWire
- 2 months ago - Bioxytran's Antiviral Breakthrough Featured in University of Georgia's $100M HPAI Poultry Innovation Grand Challenge Submission - GlobeNewsWire
- 2 months ago - Bioxytran Completes Dose Optimization of Antiviral, ProLectin-M - GlobeNewsWire
- 4 months ago - Bioxytran Marks 50 years of Mitochondrial Research with BXT-25 Advancements - GlobeNewsWire
- 4 months ago - Bioxytran Signs NDA with the University of Georgia to Evaluate Galectin Antagonists for Bird Flu Treatment in Chickens - GlobeNewsWire
- 5 months ago - Bioxytran Develops a Groundbreaking Treatment to Combat Bird Flu in Egg Laying Chickens Potentially Saving Billions - GlobeNewsWire
- 7 months ago - Bioxytran's Cancer Preprint Reveals Potential to Enhance Most Immunotherapy Drugs - GlobeNewsWire